FAQ: Everything you need to know about the $7M $SPPI $ASRT Settlement Payout
Q: What happened?
A: Spectrum Pharmaceuticals was accused of misleading investors about poziotinib’s dosing, its interactions with the FDA, and the status of the PINNACLE confirmatory study. After FDA briefing materials revealed concerns about the drug’s safety, efficacy, and dosing, $SPPI fell sharply, including a drop of more than 37% on September 20, 2022.
Q: Am I actually eligible?
A: If you bought $SPPI shares in 2022, you’re likely eligible. You don’t need to hold the stock still to claim; past losses count
Q: When is the deadline to submit a claim?
A: The current claim deadline is October 12, 2026.
Q: When do payouts happen?
A: Typically, within 4–9 months after the claim deadline. But the exact timing depends on the court and settlement administration.
Check if you're eligible and file a claim: https://11th.com/cases/sppi-investor-settlement
The $15.95M Spectrum Pharmaceuticals investor settlement is now reviewing late claims.
Investors who purchased $SPPI / $ASRT shares between 2018 and 2021 may still be eligible to participate, late claims are currently being accepted: https://11th.com/cases/spectrum-investor-settlement
Shareholders who bought $SPPI $ASRT in 2022 have until October 12, 2026 to file a claim in the $7M Spectrum Pharmaceuticals settlement.
The settlement claims that Spectrum misled investors about poziotinib's dosing strategy, its communications with the FDA, and the status of its confirmatory PINNACLE study.
Eligible investors can still submit a claim before the deadline: https://11th.com/cases/sppi-investor-settlement
Everything You Need to Know About the $15.95M $SPPI / $ASRT Settlement Payout:
Q: What happened?
A: Spectrum Pharmaceuticals ($SPPI) agreed to a $15.95 million settlement over claims that it misled investors about the effectiveness and FDA approval prospects of its lead drug candidates, Poziotinib and Rolontis. Investors alleged the company concealed poor clinical results, manufacturing issues, and regulatory risks while continuing to present the drugs as being close to approval.
Q: Am I actually eligible?
A: If you bought $SPPI shares between 2018 and 2021, you’re likely eligible. You don’t need to still hold the stock to claim; past losses count
Q: When do payouts happen?
A: Typically, within 4–9 months after the claim deadline. But the exact timing depends on the court and settlement administration.
Q: I missed the deadline. Is it too late?
A: You may still be able to file a late claim but acceptance depends on final approval by the court.
Check if you eligible and file your claim: https://11th.com/cases/spectrum-investor-settlement
The $7M Spectrum Pharmaceuticals investor settlement is now accepting claims.
Investors who purchased $SPPI /$ASRT shares in 2022 may still be eligible to participate: https://11th.com/cases/sppi-investor-settlement
@flyinghollaender at least they have to purchase it at said price and its not just awarded at $0.01. There is a compensation problem with this company. I just hope they can deliver on ct-95, and care about shareholders and not just themselves: too many small bio companies where c suite just uses it as an atm without delivering on any promises. E.g. $ASRT
$SPPI / $ASRT Settlement Update: The court has approved the $7M investor settlement.
The case alleged that Spectrum Pharmaceuticals misled the market about poziotinib’s dosing, FDA interactions, and the status of its PINNACLE confirmatory study. In September 2022, FDA briefing materials and an advisory committee meeting raised concerns about the drug’s safety, effectiveness, and approval path, causing $SPPI to fall sharply.
With the settlement now approved, eligible investors may be able to submit a claim: https://11th.com/cases/sppi-investor-settlement
$SPPI / $ASRT lost more than 88% after clinical trial failures and FDA setbacks, and the company later agreed to a $15.95M investor settlement.
If you bought or held $SPPI between 2018 and 2021, you may still be able to recover losses from, as late claims are currently being accepted: https://11th.com/cases/spectrum-investor-settlement
$ASRT Did everyone ultimately get what funds they had left coming to them at this point. I’m assuming so as just popped in To see if or what may still be going on, but no posts or such for a while now. Well here’s to lessons learned and brighter & more prosperous prospects going forward!!💵🥃
@Akidos1 @PeterDeboner
Chuckuk..
“ $ASRT I have lumped in with Monteverdelaw send an email to Juan Monteverde and ask to be included will not commnet on the action as he has a client he is working with but we shoudl be included in the class action. Keep your trading records and I sent hom ownership proof of my 14633. We will see he is a great person with a good record if he feels it is worth pursuing.”
